Koninklijke Philips Total Current Assets 2010-2024 | PHG

Koninklijke Philips total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  • Koninklijke Philips total current assets for the quarter ending September 30, 2024 were $10.918B, a 3.91% decline year-over-year.
  • Koninklijke Philips total current assets for 2023 were $10.758B, a 0.47% decline from 2022.
  • Koninklijke Philips total current assets for 2022 were $10.809B, a 11.7% decline from 2021.
  • Koninklijke Philips total current assets for 2021 were $12.242B, a 4.55% decline from 2020.
Koninklijke Philips Annual Total Current Assets
(Millions of US $)
2023 $10,758
2022 $10,809
2021 $12,242
2020 $12,825
2019 $10,594
2018 $11,305
2017 $11,435
2016 $15,575
2015 $14,094
2014 $16,491
2013 $15,241
2012 $16,112
2011 $17,382
2010 $19,385
2009 $16,608
Koninklijke Philips Quarterly Total Current Assets
(Millions of US $)
2024-06-30 $10,918
2023-06-30 $10,562
2023-03-31
2022-06-30 $10,681
2021-06-30 $11,362
2020-06-30 $10,985
2019-06-30 $10,203
2018-06-30 $10,810
2017-06-30 $17,051
2016-12-31 $15,575
2016-09-30 $14,784
2016-06-30 $14,989
2016-03-31 $13,390
2015-12-31 $14,094
2015-09-30 $13,719
2015-06-30 $13,777
2015-03-31 $14,853
2014-12-31 $16,491
2014-09-30 $15,626
2014-06-30 $14,442
2014-03-31 $14,978
2013-12-31 $15,241
2013-09-30 $15,421
2013-06-30 $14,911
2013-03-31 $15,960
2012-12-31 $16,112
2012-09-30 $15,342
2012-06-30 $15,449
2012-03-31 $17,303
2011-12-31 $17,382
2011-09-30 $16,924
2011-06-30 $17,484
2011-03-31 $18,429
2010-12-31 $19,385
2010-09-30 $17,231
2010-06-30 $17,253
2010-03-31 $17,182
2009-12-31 $16,608
2009-09-30 $17,055
2009-06-30 $15,314
2009-03-31 $15,561
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $24.269B $19.663B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $194.797B 24.85
Boston Scientific (BSX) United States $139.837B 40.20
Stryker (SYK) United States $139.395B 31.41
EssilorLuxottica (ESLOY) France $110.104B 0.00
Medtronic (MDT) Ireland $103.429B 15.36
Lonza Group Ag (LZAGY) Switzerland $43.664B 0.00
Haleon (HLN) United Kingdom $41.193B 26.76
GE HealthCare Technologies (GEHC) United States $38.725B 20.09
ResMed (RMD) United States $34.324B 28.21
Terumo (TRUMY) Japan $28.025B 39.58
Zimmer Biomet Holdings (ZBH) United States $20.811B 13.25
Insulet (PODD) United States $19.068B 75.93
Baxter (BAX) United States $15.022B 9.77
Smith & Nephew SNATS (SNN) United Kingdom $10.471B 0.00
Bio-Rad Laboratories (BIO) United States $9.568B 32.52
BellRing Brands (BRBR) United States $9.145B 36.79
Demant (WILYY) Denmark $8.596B 0.00
Lantheus Holdings (LNTH) United States $6.666B 15.49
Haemonetics (HAE) United States $3.851B 18.79
ICU Medical (ICUI) United States $3.779B 35.98
Prestige Consumer Healthcare (PBH) United States $3.656B 18.18
Perrigo (PRGO) Ireland $3.326B 9.79
Envista Holdings (NVST) United States $3.198B 23.82
QuidelOrtho (QDEL) United States $3.077B 19.81
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
Neogen (NEOG) United States $2.678B 30.90
GN Store Nord (GNNDY) Denmark $2.593B 16.63
LeMaitre Vascular (LMAT) United States $2.104B 51.14
Green Thumb Industries (GTBIF) United States $1.564B 27.37
AtriCure (ATRC) United States $1.531B 0.00
AdaptHealth (AHCO) United States $1.364B 9.75
InMode (INMD) Israel $1.335B 8.03
BioLife Solutions (BLFS) United States $1.234B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.225B 0.00
Owens & Minor (OMI) United States $1.071B 8.37
Curaleaf Holdings (CURLF) Canada $0.942B 0.00
Phibro Animal Health (PAHC) United States $0.812B 14.32
CeriBell (CBLL) United States $0.750B 0.00
Evolus (EOLS) United States $0.633B 0.00
Capricor Therapeutics (CAPR) United States $0.600B 0.00
VAREX IMAGING (VREX) United States $0.551B 24.31
Surmodics (SRDX) United States $0.549B 0.00
Omeros (OMER) United States $0.512B 0.00
Cresco Labs (CRLBF) United States $0.459B 0.00
Verano Holdings (VRNOF) United States $0.423B 0.00
ZimVie (ZIMV) United States $0.372B 31.37
Valneva SE (VALN) France $0.369B 0.00
Quanterix (QTRX) United States $0.363B 0.00
Viemed Healthcare (VMD) United States $0.310B 29.44
Biote (BTMD) United States $0.307B 6.73
Cerus (CERS) United States $0.293B 0.00
Sanara MedTech (SMTI) United States $0.282B 0.00
OraSure Technologies (OSUR) United States $0.270B 18.10
Canopy Growth (CGC) Canada $0.267B 0.00
High Tide (HITI) Canada $0.250B 103.00
Zynex (ZYXI) United States $0.249B 52.20
Aurora Cannabis (ACB) Canada $0.227B 0.00
Sanuwave Health (SNWV) United States $0.224B 3.15
Utah Medical Products (UTMD) United States $0.207B 14.26
MacroGenics (MGNX) United States $0.200B 0.00
Organigram Holdings (OGI) Canada $0.198B 0.00
Brainsway (BWAY) Israel $0.177B 94.00
TerrAscend (TSNDF) Canada $0.164B 0.00
TriSalus Life Sciences (TLSI) United States $0.157B 0.00
FitLife Brands (FTLF) United States $0.137B 17.21
Quipt Home Medical (QIPT) United States $0.129B 0.00
Jin Medical (ZJYL) China $0.126B 0.00
Veru (VERU) United States $0.114B 0.00
Fonar (FONR) United States $0.096B 10.88
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
InterCure (INCR) Israel $0.076B 0.00
INLIF (INLF) $0.068B 0.00
Rockwell Medical (RMTI) United States $0.067B 34.67
Apyx Medical (APYX) United States $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Exagen (XGN) United States $0.056B 0.00
Ayr Wellness (AYRWF) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
ImmuCell (ICCC) United States $0.046B 0.00
Modular Medical (MODD) United States $0.046B 0.00
Safety Shot (SHOT) United States $0.037B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Allurion Technologies (ALUR) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 13.30
SNDL (SNDL) Canada $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00